Product NDC: | 0085-1297 |
Proprietary Name: | PegIntron |
Non Proprietary Name: | Peginterferon alfa-2b |
Active Ingredient(s): | 120 ug/.5mL & nbsp; Peginterferon alfa-2b |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-1297 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103949 |
Marketing Category: | BLA |
Start Marketing Date: | 20010119 |
Package NDC: | 0085-1297-02 |
Package Description: | 4 CARTRIDGE in 1 CARTON (0085-1297-02) > .5 mL in 1 CARTRIDGE |
NDC Code | 0085-1297-02 |
Proprietary Name | PegIntron |
Package Description | 4 CARTRIDGE in 1 CARTON (0085-1297-02) > .5 mL in 1 CARTRIDGE |
Product NDC | 0085-1297 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Peginterferon alfa-2b |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20010119 |
Marketing Category Name | BLA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | PEGINTERFERON ALFA-2B |
Strength Number | 120 |
Strength Unit | ug/.5mL |
Pharmaceutical Classes | Interferon Alfa-2b [Chemical/Ingredient],Interferon alpha [EPC],Interferon-alpha [Chemical/Ingredient] |